News from apotex inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Mar 22, 2016, 09:13 ET Apotex Launches First Generic Version of Merck's Nasonex®

TORONTO, March 22, 2016 /PRNewswire/ - Apotex Inc. announced today that it has launched the first generic version of Merck's Nasonex®...


Mar 16, 2015, 15:42 ET Apotex announces realignment and executive leadership team to better serve the healthcare market in Canada and globally

TORONTO, March 16, 2015 /PRNewswire/ - Dr. Jeremy B. Desai, President and CEO of Apotex, announced today a significant realignment in its structure...


Feb 17, 2015, 15:50 ET Apotex Announces FDA Has Accepted For Filing its Biosimilar Application for Filgrastim (Grastofil™)

Company currently has two biosimilar applications (filgrastim [Neupogen®]) and pegfilgrastim [Neulasta®]) under active review by...


Dec 17, 2014, 10:23 ET Apotex Announces FDA Has Accepted For Filing its Biosimilar Application for Pegfilgrastim

Believed to be the First Company to Have a Biosimilar Filing Accepted for Review of Amgen's Neulasta® TORONTO, Dec. 17, 2014 /CNW/...


Sep 26, 2014, 10:34 ET Setting the Record Straight: Products are Safe and Effective

TORONTO, Sept. 26, 2014 /CNW/ - Apotex Statement: There has been a great deal of confusion regarding two of our facilities in Bangalore, India....


Sep 10, 2014, 17:06 ET Medicine to Treat 1 in 10 Haitians Arrives in Port-au-Prince

Generic Pharmaceutical Companies Aid Haiti's Battle with Chikungunya  - Health officials anticipate that up to 50 percent of the...


Aug 26, 2014, 13:27 ET Appointment Announcement - Dr. Jeremy B. Desai, President and CEO, Apotex

TORONTO, Aug. 26, 2014 /PRNewswire/ - Dr. Barry Sherman, Chairman of the Board of Apotex, is pleased to announce the appointments of Dr. Jeremy B....


Aug 26, 2014, 08:30 ET NAFTA Tribunal Decision Supports FDA and Its Actions

TORONTO, Aug. 26, 2014 /PRNewswire/ - Apotex Inc., the largest Canadian owned pharmaceutical company, announced today that an arbitration...


May 10, 2013, 19:11 ET Additional Lots Added: Voluntary Nationwide Recall of 21 Lots of Piperacillin and Tazobactam for Injection, USP 40.5 grams due to Possibility of Precipitation / Crystallization in IV Bag or IV Line Upon Reconstitution

WESTON, FL, May 10, 2013 /PRNewswire/ - Apotex Corp. announced today that it is conducting, on behalf of the manufacturer Hospira, Inc., a...


Apr 26, 2013, 18:24 ET Voluntary Nationwide Recall of 15 Lots of Piperacillin and Tazobactam for Injection, USP 40.5 Grams due to Possibility of Precipitation / Crystallization in IV Bag or IV Line Upon Reconstitution

WESTON, FL, April 26, 2013 /PRNewswire/ - Apotex Corp. announced today that it is conducting, on behalf of the manufacturer Hospira, Inc., a...


May 11, 2011, 14:48 ET APOTEX RESUMES SHIPPING TO THE U.S.

- FDA's decision to lift import alert paves the way for Apotex's oral solid dose products to be available again for US consumers;  Company...


May 10, 2011, 10:29 ET APOTEX RESUMES SHIPPING TO THE U.S.

- FDA's decision to lift import alert paves the way for Apotex's oral solid dose products to be available again for US consumers;  Company...


Oct 20, 2009, 10:00 ET Apotex to Distribute Important Transdermal System for Management of Chronic Pain in the U.S. Market

WESTON, FL, Oct. 20 /PRNewswire/ - Apotex Corp announced today that it has signed an exclusive distribution agreement with Hisamitsu Pharmaceutical...


Sep 08, 2009, 17:25 ET FDA pharmaceutical import alert

TORONTO, Sept. 8 /PRNewswire/ - Apotex today issued the following statement concerning an Import Alert issued by the US Food and Drug...


May 07, 2008, 01:00 ET Canadian Company Receives Final Tender Approval From Rwanda For Vital AIDS Drug

TORONTO, May 7 /PRNewswire/ - Apotex Inc., Canada's largest generic pharmaceutical company has successfully bid and been awarded a tender from...


Sep 21, 2007, 01:00 ET Life Saving AIDS Drug for Africa Gets Final Clearance

TORONTO, Sept. 21 /PRNewswire/ - The Federal Commissioner of Patents issued today a compulsory licence for ApoTriavir under Canada's Access to...


May 12, 2004, 01:00 ET European Agency Extends Marketing Authorization of Ferriprox(R) (Deferiprone) - Positive Decision Benefits Patients Inadequately Treated by Deferoxamine

LONDON, England, May 12 /PRNewswire/ - The European Commission has just adopted the decision of the European Agency for the Evaluation of...


Dec 18, 2003, 00:00 ET European Court Rules Against Blood Doctor, Nancy Olivieri, in her Challenge of the Marketing Authorization of Ferriprox(TM) (Deferiprone).

LUXEMBOURG, Dec. 18 /PRNewswire/ - The Court of Justice of the European Communities, Court of First Instance dismissed as inadmissible the case...


Sep 22, 2003, 01:00 ET Study Confirms Safety and Efficacy of Deferiprone

TORONTO, Sept. 22 /PRNewswire/ - A new study published in Blood reports impressive results from a large, long-term prospective study examining...


May 07, 2003, 01:00 ET New Hope For Patients Afflicted with Rare Genetic Blood Disease: Study Finds Deferiprone Provides Significantly Greater Cardiac Protection

TORONTO, May 7 /PRNewswire/ - Iron-induced heart disease is the major cause of death in patients with the genetic blood disorder, thalassemia....


Aug 25, 1997, 01:00 ET U.S. Court Dismisses Patent Infringement Case on Apotex's Ranitidine

subsidiary of Apotex Inc., from marketing generic ranitidine tablets, which Glaxo-Wellcome sells under its Zantac(R) brandname. Glaxo...